应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ESLA Estrella Immunopharma
交易中 08-15 15:42:53 EDT
1.44
+0.03
+1.77%
最高
1.46
最低
1.32
成交量
1.43万
今开
1.40
昨收
1.41
日振幅
9.93%
总市值
5,220万
流通市值
1,487万
总股本
3,638万
成交额
2.00万
换手率
0.14%
流通股本
1,036万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Estrella Immunopharma
所属市场:
NASDAQ
上市日期:
--
主营业务:
Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司,开发CD19和CD22靶向ARTEMIS T细胞疗法,有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量,改变癌症患者的生活。为了完成这一使命,该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19,一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104,它还利用Eureka的ARTEMIS技术,不仅针对CD19,还针对CD22,一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。
发行价格:
--
{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.435,"timestamp":1723750558952,"preClose":1.41,"halted":0,"volume":14261,"delay":0,"floatShares":10363303,"shares":36376293,"eps":-0.319206,"marketStatus":"交易中","marketStatusCode":2,"change":0.025,"latestTime":"08-15 15:42:53 EDT","open":1.4,"high":1.46,"low":1.32,"amount":19964.183536700002,"amplitude":0.099291,"askPrice":1.46,"askSize":100,"bidPrice":1.41,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-0.319206,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723752000000},"adr":0,"adjPreClose":1.41,"preHourTrading":{"tag":"盘前","latestPrice":1.388,"preClose":1.41,"latestTime":"08:16 EDT","volume":2,"amount":2.848,"timestamp":1723724171931},"postHourTrading":{"tag":"盘后","latestPrice":1.34,"preClose":1.46,"latestTime":"16:50 EDT","volume":169,"amount":226.46,"timestamp":1723668641430},"volumeRatio":0.886249},"requestUrl":"/m/hq/s/ESLA","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.eurekatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0542},{"period":"1month","weight":-0.0267},{"period":"3month","weight":0.3905},{"period":"6month","weight":0.3273},{"period":"1year","weight":-0.8164},{"period":"ytd","weight":0.3153}],"compareEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.0317},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0886},{"period":"1year","weight":0.2277},{"period":"ytd","weight":0.144}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司,开发CD19和CD22靶向ARTEMIS T细胞疗法,有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量,改变癌症患者的生活。为了完成这一使命,该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19,一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104,它还利用Eureka的ARTEMIS技术,不仅针对CD19,还针对CD22,一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.016322},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.027552},{"month":3,"riseRate":0.666667,"avgChangeRate":0.068576},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.046969},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.031798},{"month":6,"riseRate":0.666667,"avgChangeRate":0.039731},{"month":7,"riseRate":0.666667,"avgChangeRate":0.139894},{"month":8,"riseRate":0,"avgChangeRate":-0.113059},{"month":9,"riseRate":1,"avgChangeRate":0.140224},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.274233},{"month":11,"riseRate":1,"avgChangeRate":0.022767},{"month":12,"riseRate":0,"avgChangeRate":-0.114712}],"exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}